Serum adenosine deaminase levels in pancreatic diseases

Pancreatology

Volumn 7, Issue 5-6, 2007, Pages 526-530

  Ibiş, Mehmet ^c   Köklü, Seyfettin ^b,e   Yilmaz, Fatma Meriç ^b   Başar, Ömer ^a   Yilmaz, Gülsen ^b   Yüksel, Osman ^d   Yildirim, Emre ^b   Öztürk, Zeynel Abidin ^b  

^a DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^d ANKARA NUMUNE HOSPITAL   (Turkey)

^e NONE   (Turkey)

Author keywords

Adenosine deaminase; Cancer, pancreas; Pancreatitis, acute chronic

Indexed keywords

ADENOSINE DEAMINASE; BIOLOGICAL MARKER; CHEMOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; PANCREAS CANCER; PANCREAS DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 35348818792     PISSN: 14243903     EISSN: 14243911     Source Type: Journal    
DOI: 10.1159/000108970     Document Type: Article

References (40)

1. Lizuka H, Koizumi H, Kamikagi K, et al: Two forms of adenosine deaminase in pig epidermis. J Dermatol 1981;18:91-95.
2. Schrader WP, West CA: Adenosine deaminase complexing proteins are localized in exocrine glands of the rabbit. J Histochem Cytochem 1985;33:508-614.
3. Dinjens WN, ten Kate J, van der Linden EP, et al: Distribution of adenosine deaminase complexing protein in human tissues. J Histochem Cytochem 1989;37:1869-1875.
4. Sullivan J, Osborne WR, Wedgewood RJ: Adenosine deaminase activity in lymphocytes. Br J Haematol 1977;37:157-158.
5. Kose K, Yazici C, Ascioglu O: The evaluation of lipid peroxidation and adenosine deaminase activity in patients with Behcet's disease. Clin Biochem 2001;34:125-129.
6. Stancikova M, Lukac J, Istok R, et al: Serum adenosine deaminase activity and its isoenzyme pattern in patients with systemic lupus erythematosus. Clin Exp Rheumatol 1998;16:583-586.
7. Hitoglou S, Hatzistilianou M, Gougoustamou D, et al: Adenosine deaminase activity and its isoenzyme pattern in patients with juvenile rheumatoid arthritis and systemic lupus erythematosus. Clin Rheumatol 2001;20:411-416.
8. Meunier P, Filipe P, Emerit I, et al: Deaminase in progressive systemic sclerosis. Acta Dermatol Venereol 1995;75:297-299.
9. Canbolat O, Akyol O, Kavutcu M, et al: Serum adenosine deaminase and total superoxide dismutase activities before and after surgical removal of cancerous laryngeal tissue. J Laryngol Otol 1994;108:849-851.
10. Lal H, Munjal SK, Wig U, et al: Serum enzymes in head and neck cancer III. J Laryngol Otol 1987;101:1062-1065.
11. Walia M, Mahajan M, Singh K: Serum adenosine deaminase, 5′-nucleotidase and alkaline phosphates in breast cancer patients. Indian J Med Res 1995;101:247-249.
12. Nishihara H, Akedo H, Okada H, et al: Multienzyme patterns of serum adenosine deaminase by agar gel electrophoresis: an evaluation of the diagnostic value in lung cancer. Clin Chim Acta 1970;30:251-258.
13. Durak I, Isik AU, Canbolat O, et al: Adenosine deaminase 5′ nucleotidase superoxide dismutase and catalase activities in cancerous and non-cancerous human laryngeal tissues. Free Radic Biol Med 1993;15:681-684.
14. Dasmahapatra KS, Facs HZK, Dasmahapatra A, et al: Evaluation of adenosine deaminase activity in patients with head and neck cancer. J Surg Res 1986;40:363-373.
15. Giusti G: Adenosine deaminase;in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York, Academic Press, 1974, pp 1092-1099.
16. Werner J, Hartwig W, Uhl W, et al: Useful markers for predicting severity and monitoring progression of acute pancreatitis. Pancreatology 2003;3:115-127.
17. Bhatia M, Brady M, Shokuhi S, et al: Inflammatory mediators in acute pancreatitis. J Pathol 2000;190:117-125.
18. Bhatia M, Neoptolemos JP, Slavin J: Inflammatory mediators as therapeutic targets in acute pancreatitis. Curr Opin Investig Drugs 2001;2:496-501.
19. Bhatia M: Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome. Curr Drug Targets Inflamm Allergy 2002;1:343-351.
20. Bhatia M: Novel therapeutic targets for acute pancreatitis and associated multiple organ dysfunction syndrome: an update. Med Chem Rev Online 2004;1:25-26.
21. Makhija R, Kingsnorth AN: Cytokine storm in acute pancreatitis. J Hepatobiliary Pancreat Surg 2002;9:401-410.
22. Pezzilli R, Ceciliato R, Barakat B, et al: Immune manipulation of the inflammatory response in acute pancreatitis. What can be expected? J Pancreas 2004;5:115-121.
23. McKay CJ, Gallagher G, Brooks B, et al: Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg 1996;83:919-923.
24. Saurer L, Reber P, Schaffner T, et al: Differential expression of chemokines in normal pancreas and in chronic pancreatitis. Gastroenterology 2000;118:356-367.
25. Stevens T, Conwell DL, Zuccaro G: Pathogenesis of chronic pancreatitis: an evidencebased review of past theories and recent developments. Am J Gastroenterol 2004;99:2256-2270.
26. Barton RW, Goldshneider I: Nucleotide metabolizing enzymes and lymphocytic differentiation. Mol Cell Biochem 1979;28:135-147.
27. Giblett ER, Anderson JE, Cohen F, et al: Adenosine deaminase deficiency in two patients with severely impaired cellular immunity. Lancet 1972;2:1067-1069.
28. Yamashita N, Kaneoka H, Kaneko S, et al: Role of gamma delta T lymphocytes in the development of Behcet's disease. Clin Exp Immunol 1997;107:241-247.
29. Mosmann TR, Cherwinski H, Bond MW, et al: Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
30. Koizumi H, Tomizawa K, Tanaka H, et al: Clinical significance of serum adenosine deaminase activity in patients with mycosis fungoides. J Dermatol 1993;20:394-397.
31. Bukulmez G, Akan T, Ciliv G: Serum adenosine deaminase levels in patients with psoriasis: a prospective case-control study. Eur J Dermatol 2000;10:274-276.
32. Nishikawa Y, Nakamura M, Fukumoto K, et al: Adenosine deaminase isoenzymes in patients with Graves' disease. Rinsho Byori 1995;43:1057-1060.
33. Ida T, Taniai S, Nitta M, et al: Serum adenosine deaminase (ADA) activity in patients with active pulmonary tuberculosis. Kekkaku 1990;65:477-481.
34. Durak I, Perk H, Kavutcu M, et al: Adenosine deaminase, 5′nucleotidase, xanthine oxidase, superoxide dismutase, and catalase activities in cancerous and noncancerous human bladder tissues. Free Radic Biol Med 1994;16:825-831.
35. Eroglu A, Canbolat O, Demirci S, et al: Activities of adenosine deaminase and 5′-nucleotidase in cancerous and noncancerous human colorectal tissues. Med Oncol 2000;17:319-324.
36. Saracoglu U, Guven O, Durak I: Adenosine deaminase and 5′-nucleotidase activities in saliva from patients with oral and laryngeal cancer. Oral Dis 2005;11:323-325.
37. Camici M, Tozzi MG, Allegrini S, et al: Purine salvages enzyme activities in normal and neoplastic human tissues. Cancer Biochem Biophys 1990;11:201-209.
38. Dornard J, Bonnafous JC, Favero J, et al: Ecto-5′nucleotidase and adenosine deaminase activities of lymphoid cells. Biochem Med 1982;28:144-156.
39. Katz MH, Savides TJ, Moossa AR, et al: An evidence-based approach to the diagnosis and staging of pancreatic cancer. Pancreatology 2005;5:576-590.
40. Aghaei M, Karami-Tehrani F, Salami S, et al: Adenosine deaminase activity in the serum and malignant tumors of breast cancer: the assessment of isoenzyme ADA1 and ADA2 activities. Clin Biochem 2005;38:887-891.